Stem Cell Therapy for Heart Failure

Table of Contents Stem Cell Therapy for Heart Failure Ensuring Regenerative Proficiency How much does stem cell therapy cost? Giostar's aproach to Stem Cell Therapy Stem cell therapy in Mexico Why Choose GIOSTAR Mexico? Stem Cell Research References for Heart Conditions

Stem cell therapy for heart failure ensuring regenerative proficiency 

The use of mesenchymal stem cells has shown to improve the cardiac structure and function, functional capacity and the patient's quality of life, thanks to the properties that stem cells have to reduce fibrosis in the heart. Stem cell therapy has demonstrated to benefit the heart by stimulating the natural regenerative response of the body. 

The use of mesenchymal stem cells has shown to improve the cardiac structure and function, functional capacity and the patient's quality of life, thanks to the properties that stem cells have to reduce fibrosis in the heart. Stem cell therapy has demonstrated to benefit the heart by stimulating the natural regenerative response of the body.  (3)

Administration of mesenchymal stem cells (MSCs) to diseased hearts improves cardiac function and reduces scar size. These effects occur via the stimulation of endogenous repair mechanisms, including regulation of immune responses, tissue perfusion, inhibition of fibrosis, and proliferation of resident cardiac cells. (4)

The last two decades have witnessed the development of novel regenerative medicine approaches for cardiovascular diseases. However, the ultimate goal of complete repair of the heart in response to damage has yet to be realized.

How much does stem cell therapy cost?

The cost of Stem Cell Therapy needs to be determined by our expert medical team, as prices depend on the specific condition and personalized medical recommendations. Our dedicated team of medical professionals carefully evaluates each patient's unique health situation to recommend the most effective therapy. Stem Cell Therapy includes the following:

• • Laboratory protocol by Dr. Anand (activation of the stem cells to direct them towards the affected tissue or organ)
  • 1 - 3 stem cell vials (35 - 105 million stem cells)
  • 1 - 10 billion exosomes (volume depends on the doctor's personal evaluation of each patient)
  • Oxygen Therapy
  • Body preparation
  • Medical Consultation
  • Dietitian Follow-up post-therapy
  • Transportation hotel-clinic in local shuttle
  • Lodging (available in our Clinic in Algodones) at Hotel Hacienda or Hotel Cielito Lindo
  • Preferential prices for future reinforcements/applications

Giostar's Approach to Stem Cell Therapy

Being part of the last three decades of innovative discoveries in the research-based area of regenerative medicine, Stem Cell Therapy promotes the reduction and stoppage of degenerative diseases or conditions, such as ALS, physical injuries and aging, bolstering the regeneration of damaged tissues, bodily processes and overall well-being.

Giostar Mexico specializes in medical tourism, receiving patients from all over the world. With the acquired understanding based on scientific research, we are able to provide personalized protocols to each patient. Through specialized allogenic mesenchymal adult stem cells, our regenerative therapy concentrates stem cells in the targeted area, organ or immune system, helping the body stop the progression of a disease or condition and begin regeneration. 

Stem cell therapy in Mexico

• Is stem cell therapy safe and legal in Mexico?

An important question our patients ask before coming to our clinics is: Is stem cell therapy safe? We also understand that, perhaps, the real question is: 

• Is stem cell therapy legal in Mexico? Yes and of course! 

In Giostar Mexico, we ask for each applicant to submit a health history form, from which our medical directors personally evaluate the viability of each applicant. This means that stem cell therapy may not be for everyone. 

Stem cell therapy is thoroughly regulated by the Mexican FDA equivalent: COFEPRIS. Due to advanced legislation, Mexico enjoys sufficient regulatory framework to offer applications otherwise unavailable in countries such as the US or Canada, for example, local direct applications (hands for arthritis, shoulder pain, knee pain), lumbar and cervical applications, all of which have proven better results for patients, than just receiving stem cell therapy intravenously.

Why Choose GIOSTAR Mexico?

GIOSTAR Mexico stands out for its commitment to personalized therapy for various diseases. Recognizing that each patient is unique, we develop tailored protocols to cater to individual differences influenced by genetics and other factors.

To further facilitate access to stem cell therapy, we are pleased to announce our partnership with United Credit, offering eligible US citizens up to $25,000.00 USD in credit for treatment costs. Stem cell therapy, a cornerstone of regenerative medicine, aims to slow down or halt deterioration and even regenerate damaged tissues and organs. By completing our health history form, patients enable our medical staff to determine therapy suitability and craft personalized treatment plans to address specific health conditions.

Stem cell research references for heart conditions

1. Abdelwahid, E., Siminiak, T., Guarita-Souza, L. C., Teixeira de Carvalho, K. A., Gallo, P., Shim, W., & Condorelli, G. (2011). Stem cell therapy in heart diseases: a review of selected new perspectives, practical considerations and clinical applications. Current cardiology reviews, 7(3), 201–212. https://doi.org/10.2174/157340311798220502
2. Toth PP, Shammas NW, Foreman B, Byrd JB, Brook RD. Cardiovascular disease. In: Rakel RE, Rakel DP, eds. Textbook of Family Medicine. 9th ed. Philadelphia, PA: Elsevier Saunders; 2016:chap 27.
3. Yajun Guo, Yunsheng Yu, Shijun Hu, Yueqiu Chen and Zhenya Shen1. (2020). The therapeutic potential of mesenchymal stem cells for cardiovascular diseases. Cell Death & Disease, -, 10. 10/07/2021.
4. Bagno et al., Mesenchymal Stem Cell-Based Therapy for Cardiovascular Disease: Progress and Challenges, Molecular. Therapy (2018), https://doi.org/10.1016/j.ymthe.2018.05.009